FORTITUDE Clinical Trials
The FORTITUDE-101 and FORTITUDE-102 trials are currently enrolling adults with previously untreated advanced or metastatic stomach or gastroesophageal junction (GEJ) cancer.
The FORTITUDE-101 and FORTITUDE-102 trials are currently enrolling adults with previously untreated advanced or metastatic stomach or gastroesophageal junction (GEJ) cancer.